As a rule, EGFR-dependent cancer cell lines that have undergone EMT as a mechanism of acquired resistance fail to exhibit previously documented molecular events such as selection for the EGFR T790 M gate-keeper mutation or MET amplification [18]. This evidence concerns the gene MET and cancer.